Open AccessCorrection: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
Author(s) -
Lisa Aniek de Jong,
Jessie Groeneveld,
Jelena Stevanović,
H. Rila,
Robert G. Tieleman,
Menno V. Huisman,
Maarten J. Postma,
Marinus van Hulst
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0266625
Subject(s) - apixaban , atrial fibrillation , medicine , cardiology , medline , rivaroxaban , intensive care medicine , warfarin , chemistry , biochemistry